<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The main cause of <z:hpo ids='HP_0011420'>death</z:hpo> for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients is the development of metastatic lesions at sites distant from the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, it is important to find biomarkers that are related to the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and to study the possible mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>Recent data have shown that soluble attractant molecules called chemokines support the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of certain <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> to certain organs </plain></SENT>
<SENT sid="3" pm="."><plain>To identify molecular regulators that are differentially expressed in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, PCR array analysis was performed and CC chemokine ligand 7 (CCL7) showed remarkable overexpression in liver <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumor</z:e> tissues </plain></SENT>
<SENT sid="4" pm="."><plain>To validate the results of the PCR array, 30 patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> were selected </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry and real-time PCR analysis showed that CCL7 was expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> colonic epithelium and the expression was higher in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> compared to primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Real-time PCR showed that the expression of CCR1, CCR2 and CCR3 was also higher in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> compared to primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p=0.001, p=0.033 and p&lt;0.001, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, correlation of CCL7 overexpression and its receptor expression with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> suggests that CCL7 as a novel target in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> may be of potential clinical value for the prevention of hepatic recurrences </plain></SENT>
</text></document>